Clinical trials: Contraceptive Implant
Implant Complication, Contraceptive Device; Complications
Improvement of Symptoms After Removal of the Essure® Contraceptive Implant
ESSURE® is an implantable medical device for definitive and irreversible sterilization indicated for adult women of childbearing age. These implants are inserted into the fallopian tubes by hysteroscopy.
- Trial name
- ABLES (NCT06355713)
- Testing
- Magnetic resonance imaging- Positron Emission Tomography (MRI-PET) examination, blood sample, urine collection
- Where
- 10 sites in France
- Volunteers
- 444 people
- Sponsor
- Hospices Civils de Lyon
IUD, Contraceptive Implant
Quick Start of Highly Effective Contraception
This project will quantify rates of contraceptive failure when unprotected intercourse occurs 6-14 days prior to initiation of highly effective reversible contraceptives (such as IUD's and Implants).
- Conditions
- IUD, Contraceptive Implant, Contraception, Birth Control
- Trial name
- NCT02076217
- Testing
- Copper T-380 IUD, LNG IUD, Contraceptive implant Nexplanon
- Where
- United States
- Volunteers
- 270 people
- Sponsor
- University of Utah
Contraception, Intrauterine Device
Structured Contraceptive Counseling During Pregnancy
Unintended pregnancy is common among women of fertile age, and also among those who have recently given birth. A Swedish study has shown that about 7.7% experience a new pregnancy, and that 2.5% will have an abortion between…
- Conditions
- Contraception, Intrauterine Device, Contraceptive Implant, Long-acting Reversible Contraception
- Trial name
- NCT05550064
- Testing
- Structured contraceptive counseling
- Where
- 4 sites in Sweden
- Volunteers
- 160 people, healthy volunteers welcome
- Sponsor
- Dalarna University
Etonogestrel Contraceptive Implant, Bothersome Bleeding
Use of Norethindrone Acetate for Management of Bleeding Associated With the Etonogestrel Contraceptive Implant
The overall objective of this study is to confirm that oral progesterone is an effective way to manage bothersome bleeding; thus increasing the rate of continuation of the etonogestrel contraceptive implant in adolescents.
- Trial name
- NCT02353247
- Testing
- Norethindrone acetate
- Where
- United States
- Volunteers
- 88 people
- Sponsor
- Norton Healthcare
Removal of a Contraceptive Subdermal Implant
Safe Access: Trial With RemovAid Device
This randomized trial will compare different approaches to removing a subdermal contraceptive implant from the upper arm of 225 women in Uganda.
- Trial name
- NCT04120337
- Testing
- RemovAid device + lidocaine patch, Standard technique + lidocaine injection, RemovAid device + lidocaine injection
- Where
- Uganda
- Volunteers
- 225 people, healthy volunteers welcome
- Sponsor
- RemovAid AS
Women With an ENG Contraceptive Implant
Identification and Removal of the Non Palpable Etonogestrel Contraceptive Implant
This study will investigate in-office ultrasound localization vs localization in radiology for identification and removal of non palpable etonogestrel (ENG) contraceptive implants and aims to help establish best practices in this…
- Trial name
- ENG (NCT02986204)
- Testing
- removal of ENG implant, continuation of ING implant
- Where
- United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- University of California, Los Angeles
Removal Contraceptive Implant
Investigation to Evaluate Performance and Safety of RemovAid ™ in Removal of Contraceptive Implants
The safety and efficacy of a subdermal implant retrieval device (RemovAid) is investigated in a population of 25 women seeking removal of their palpable contraceptive implants.
- Trial name
- REVALID03 (NCT03912649)
- Testing
- RemovAid
- Where
- Sweden
- Volunteers
- 15 people
- Sponsor
- RemovAid AS
Contraceptive Implant Utilization, Lactation
Immediate Versus Interval Postpartum Use of the Levonorgestrel Contraceptive Implants: a Randomized Controlled Trial
This study will evaluate if immediate postpartum placement of a levonorgestrel (LNG) contraceptive implant within 5 days of delivery improves implant utilization at 6 months postpartum compared to implant placement at 6-8 weeks…
- Trial name
- NCT02341027
- Testing
- Jadelle
- Where
- Uganda
- Volunteers
- 205 people
- Sponsor
- University of California, San Francisco
Removal of Contraceptive Implant
Pilot Removal of Palpable Subdermal Contraceptive Rod Implants
There are no implant removal devices on the market by any manufacturer. Overall, the RemovAid™ combines the features of fixation, incision and extraction.
- Trial name
- REVALID02 (NCT03356119)
- Testing
- RemovAid device
- Where
- Sweden
- Volunteers
- 19 people
- Sponsor
- RemovAid AS
Removal of Contraceptive Implant
Removal of Palpable Subdermal Contraceptive Rod Implants.
There are no implant removal devices on the market by any manufacturer. New features are described in comparison with the existing removal technique.
- Trial name
- NCT02986971
- Testing
- New IMD
- Where
- Sweden
- Volunteers
- 22 people
- Sponsor
- RemovAid AS
Continuation Rate of Contraceptive Implant
Immediate vs. Delayed Postpartum Etonogestrel Implant
The investigators are examining if there is a difference in continuation rates of the etonogestrel contraceptive implant between women who have the device placed immediately after delivery, before leaving the hospital, and women…
- Trial name
- NCT01767285
- Testing
- Etonogestrel implant
- Where
- United States
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Duke University
Women Wanting Contraceptive Implant for Pregnancy Prevention
A Trial on the Effect of Sino-implant (II) Use on Condom Use Among Women in Kingston, Jamaica
This unblinded, randomized controlled trial (RCT) among women to determine: 1)if unprotected sex as measured prostate-specific antigen (PSA) will be more among women who receive a contraceptive implant immediately at baseline…
- Trial name
- SIS (NCT01684358)
- Testing
- Sino-implant (II)
- Where
- Jamaica
- Volunteers
- 414 people, healthy volunteers welcome
- Sponsor
- Centers for Disease Control and Prevention